Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03821948 · ClinicalTrials.gov registry record
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
A clinical trial, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 5,131
- Enrollment target
NCT03821948: Completed study, sponsored by Exact Sciences Corporation.
NCT03821948 is a clinical trial that has completed, run by Exact Sciences Corporation. The registered enrollment target is 5,131 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03821948 has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 5,131 participants
- Enrollment target
Study Summary
The primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of new biomarker assays for detection of colorectal cancer (CRC).
Primary Outcome
The outcomes are co-primary. Biomarkers under evaluation include differential methylation of nucleic acids and altered expression of proteins in stool from subjects at average risk or increased risk for development of colorectal cancer at the pre-intervention stage.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,131 participants |
| Start Date | 2019-01-03 |
| Est. Completion | 2020-05-15 |
What the finished NCT03821948 record still lists
NCT03821948 is an observational study that tracks outcomes without assigning an intervention. Its 5,131 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03821948 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03821948 about?
NCT03821948 is a clinical study titled "Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold". The primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of new biomarker assays for detection of colorectal cancer (CRC).
What is the current status of trial NCT03821948?
This trial is currently completed. The enrollment target is 5,131 participants. The study started on 2019-01-03. Estimated completion is 2020-05-15.
Who is sponsoring clinical trial NCT03821948?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06535867 · 5,122 participants
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
- NCT05018611 · 5,100 participants · NA
Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW
- NCT05701358 · 5,100 participants · NA
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
- NCT05135403 · 5,179 participants
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI